DHSC has “overseen years of decline in the NHS’s cancer and elective care”
16 March 2022
Waits dependent on a postcode lottery there is “no national plan to address”
In its report today the Public Accounts Committee says the Department for Health and Social Care “has overseen years of decline in the NHS’s cancer and elective care waiting time performance and, even before the pandemic, did not increase capacity sufficiently to meet growing demand.”
- Read the full report (HTML)
- Read the full report (PDF)
- Read the report summary
- Find all publications related to this inquiry, including oral and written evidence
The NHS has not met the 18-week maximum waiting time standard for elective care since February 2016 nor the eight key standards for cancer care in totality since 2014. The Committee says now that “on top of these previous failures and despite the heroic efforts of the NHS workforce, the COVID-19 pandemic has inevitably caused a further huge deterioration in the NHS’s provision of elective and cancer care.”
At the end of December 2021, 6.07 million patients were waiting for ‘elective’ care - such as hip or knee replacements or cataract surgery - the biggest waiting list since records began.
The legal standard for elective care states that 92% of people on the waiting list should be seen within 18 weeks, but only 64% (3.87 million) of these patients have been waiting less than that, and 311,000 have now been waiting for more than a year. Even before the pandemic only 83% were being seen within 18 weeks.
Only 67% of patients with an urgent referral for suspected cancer were treated within 62 days, compared to the requirement for 85% to be treated within that time.
The Committee also notes “a striking feature of the pandemic was that very large numbers of patients did not present at, or were unable to access, routine NHS services”. As of September 2021, there were between 7.6 million and 9.1 million missing referrals of patients for elective care and between 240,000 and 740,000 missing urgent referrals for suspected cancer. People will face serious health consequences as a result of delays in treatment, with some dying earlier and many living with pain or discomfort for longer.
The Committee says “any transparent and realistic assessment of what the Department and NHSE&I expect elective and cancer care services to achieve by 2024-25” must include an “assessment of the number of staff that will be available and how staff who have been working under intense and consistent pressure will be supported”.
Dame Meg Hillier MP, Chair of the Public Accounts Committee, said:
“DHSC has overseen a long-term decline in elective and critical cancer care that is dragging our National Health Service and the heroic staff down. We on PAC are now extremely concerned that there is no real plan to turn a large cash injection, for elective care and capital costs of dangerously crumbling facilities, into better outcomes for people waiting for life-saving or quality-of-life improvng treatment. Nor is it obvious that the Department finally understands that it’s biggest problem, and the only solution to all its problems, is the way it manages its greatest resource: our heroic NHS staff. Exhausted and demoralised, they’ve emerged from two hellish years only to face longer and longer lists of sicker people. And this is compounded by staffing shortages in a number of professional areas.
The cycle of glib headlines and fiddling with management structures must be broken, with an overhauled “people plan” that gets to the core of the desperate under-staffing and under-resourcing that have undermined our health system.”
- Inquiry: NHS Backlogs and waiting times
- Public Accounts Committee
- About Parliament: Select committees
- Visiting Parliament: Watch committees